Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

SOHO 2025 | Guidance for junior researchers entering the cellular therapy field

In this video, Yi Lin, MD, PhD, Mayo Clinic, Rochester, MN, offers guidance to junior researchers entering the cellular therapy field, emphasizing the vast nature of the field and the many options available to young investigators. This interview took place at the 13th Annual Meeting of the Society of Hematologic Oncology (SOHO 2025) in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

You know this is a very, very exciting time to be coming into medicine. I think for cellular therapy, it’s really being studied even beyond the hematology and medical oncology space into other diseases where the immune system plays a role. And so for young investigators coming in, whether they’re focused on, interested in a particular disease and trying to see if there’s a role for cell therapy in that, or they’re very interested in cell therapy and more open to identifying ways to make cell therapy work better and seeing what disease you know that could be used for, I think either one would be very good approaches...

You know this is a very, very exciting time to be coming into medicine. I think for cellular therapy, it’s really being studied even beyond the hematology and medical oncology space into other diseases where the immune system plays a role. And so for young investigators coming in, whether they’re focused on, interested in a particular disease and trying to see if there’s a role for cell therapy in that, or they’re very interested in cell therapy and more open to identifying ways to make cell therapy work better and seeing what disease you know that could be used for, I think either one would be very good approaches. So it’s really the options are wide open. I don’t think there’s necessarily one track or one, you know, best track to get into cell therapy. Similarly, some people may be interested in more benchtop work or more, what we call dry science, you know, informatics and AI, or clinical application. So there’s a role now that cell therapy is in standard of care practice for all different aspects of clinical and translational and basic science to advance the field. So I think it is very much kind of merging what the young investigator is really passionate about to build their research and see where’s that opportunity to use that in the cell therapy field.

 

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...